TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research. July 18, 2008